Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of DKK 1.92 trillion. The enterprise value is 1.99 trillion.

Market Cap	1.92T
Enterprise Value	1.99T

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.71% in one year.

Current Share Class	n/a
Shares Outstanding	4.44B
Shares Change (YoY)	-0.71%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	33.83%
Float	3.18B

Valuation Ratios

The trailing PE ratio is 19.09 and the forward PE ratio is 15.83. Novo Nordisk's PEG ratio is 1.04.

PE Ratio	19.09
Forward PE	15.83
PS Ratio	6.63
PB Ratio	13.37
P/TBV Ratio	59.19
P/FCF Ratio	25.98
P/OCF Ratio	n/a
PEG Ratio	1.04

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.46, with an EV/FCF ratio of 27.02.

EV / Earnings	19.75
EV / Sales	6.87
EV / EBITDA	13.46
EV / EBIT	14.26
EV / FCF	27.02

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.72.

Current Ratio	0.74
Quick Ratio	0.52
Debt / Equity	0.72
Debt / EBITDA	0.69
Debt / FCF	1.39
Interest Coverage	85.29

Financial Efficiency

Return on equity (ROE) is 80.78% and return on invested capital (ROIC) is 46.03%.

Return on Equity (ROE)	80.78%
Return on Assets (ROA)	22.41%
Return on Invested Capital (ROIC)	46.03%
Return on Capital Employed (ROCE)	56.34%
Revenue Per Employee	3.78M
Profits Per Employee	1.31M
Employee Count	77,349
Asset Turnover	0.74
Inventory Turnover	1.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.84% in the last 52 weeks. The beta is 0.20, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	-50.84%
50-Day Moving Average	570.07
200-Day Moving Average	754.37
Relative Strength Index (RSI)	22.63
Average Volume (20 Days)	5,511,051

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of DKK 290.40 billion and earned 100.99 billion in profits. Earnings per share was 22.63.

Revenue	290.40B
Gross Profit	246.84B
Operating Income	139.88B
Pretax Income	127.19B
Net Income	100.99B
EBITDA	146.67B
EBIT	139.88B
Earnings Per Share (EPS)	22.63

Full Income Statement

Balance Sheet

The company has 26.31 billion in cash and 102.79 billion in debt, giving a net cash position of -76.48 billion or -17.23 per share.

Cash & Cash Equivalents	26.31B
Total Debt	102.79B
Net Cash	-76.48B
Net Cash Per Share	-17.23
Equity (Book Value)	143.49B
Book Value Per Share	32.31
Working Capital	-56.63B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 120.97 billion and capital expenditures -47.16 billion, giving a free cash flow of 73.80 billion.

Operating Cash Flow	120.97B
Capital Expenditures	-47.16B
Free Cash Flow	73.80B
FCF Per Share	16.63

Full Cash Flow Statement

Margins

Gross margin is 85.00%, with operating and profit margins of 48.17% and 34.78%.

Gross Margin	85.00%
Operating Margin	48.17%
Pretax Margin	43.80%
Profit Margin	34.78%
EBITDA Margin	50.51%
EBIT Margin	48.17%
FCF Margin	25.41%

Dividends & Yields

This stock pays an annual dividend of 11.40, which amounts to a dividend yield of 2.50%.

Dividend Per Share	11.40
Dividend Yield	2.50%
Dividend Growth (YoY)	21.28%
Years of Dividend Growth	7
Payout Ratio	43.71%
Buyback Yield	0.71%
Shareholder Yield	3.20%
Earnings Yield	5.27%
FCF Yield	3.85%

Dividend Details

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 8.94.

Altman Z-Score	8.94
Piotroski F-Score	n/a